Cargando…

The Coronavirus Disease Pandemic Continues to Challenge Patients in Need of Buprenorphine for Opioid Use Disorder

Detalles Bibliográficos
Autores principales:	Routsolias, Joanne C., Mycyk, Mark B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Emergency Nurses Association. Published by Elsevier Inc. 2021
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7862878/ https://www.ncbi.nlm.nih.gov/pubmed/33985666 http://dx.doi.org/10.1016/j.jen.2021.01.011

Ejemplares similares

Opioid Substitution Treatment Using Buprenorphine for Management of Dependence on Natural Opioids: Case Series
por: Kathiresan, Preethy, et al.
Publicado: (2019)

Comment on “A Comparison of Buprenorphine + Naloxone to Buprenorphine and Methadone in the Treatment of Opioid Dependence During Pregnancy: Maternal and Neonatal Outcomes”
por: Newman, Robert G., et al.
Publicado: (2013)

Depot buprenorphine injections for opioid use disorder: Patient information needs and preferences
por: Neale, Joanne, et al.
Publicado: (2019)

Patients Maintained on Buprenorphine for Opioid Use Disorder Should Continue Buprenorphine Through the Perioperative Period
por: Lembke, Anna, et al.
Publicado: (2019)

Pharmacy Availability of Buprenorphine for Opioid Use Disorder Treatment in the US
por: Weiner, Scott G., et al.
Publicado: (2023)

How Can We “Get the Lead Out” Without Chelators?
por: Mazer-Amirshahi, Maryann, et al.
Publicado: (2021)

Changes in US Clinician Waivers to Prescribe Buprenorphine Management for Opioid Use Disorder During the COVID-19 Pandemic and After Relaxation of Training Requirements
por: Spetz, Joanne, et al.
Publicado: (2022)

Trends in Buprenorphine Prescribing for Opioid Use Disorder by Psychiatrists in the US From 2003 to 2021
por: Creedon, Timothy B., et al.
Publicado: (2023)

Prescribing of Opioid Analgesics and Buprenorphine for Opioid Use Disorder During the COVID-19 Pandemic
por: Currie, Janet M., et al.
Publicado: (2021)

Buprenorphine‐naloxone, buprenorphine, and methadone throughout pregnancy in maternal opioid use disorder
por: Kanervo, Minna M., et al.
Publicado: (2022)

Managing opioid withdrawal precipitated by buprenorphine with buprenorphine
por: Oakley, Bridget, et al.
Publicado: (2021)

The Pharmacology of Buprenorphine Microinduction for Opioid Use Disorder
por: De Aquino, Joao P., et al.
Publicado: (2021)

Psychiatric comorbidities and their treatment predict buprenorphine continuation among postpartum people with opioid use disorder
por: Shadowen, Hannah, et al.
Publicado: (2022)

Strategies to maintain persistence of opioid agonist therapy during the novel coronavirus pandemic in Taiwan
por: Shih, Cheng-Chan, et al.
Publicado: (2020)

Infectious Disease (ID) Learning Unit: What the ID Clinician Needs to Know About Buprenorphine Treatment for Opioid Use Disorder
por: Westlake, Amanda A., et al.
Publicado: (2016)

The Emergency Challenges of Coronavirus Disease 2019 Pandemic in Brazilian Favelas: How to Face it?
por: Teixeira, Samuel Cota
Publicado: (2021)

Personalized Care in Opioid Use Disorder maintained on Buprenorphine
por: Elarabi, H., et al.
Publicado: (2022)

Inpatient Buprenorphine Induction for Opioid Use Disorder in Pregnancy
por: Tavakoli, Amin, et al.
Publicado: (2023)

Transforming a PICU Into an Adult ICU During the Coronavirus Disease 2019 Pandemic: Meeting Multiple Needs
por: Levin, Amanda B., et al.
Publicado: (2020)

Opioid substitution treatment with sublingual buprenorphine in Manipur and Nagaland in Northeast India: what has been established needs to be continued and expanded
por: Kumar, M Suresh, et al.
Publicado: (2009)

Comparison of Buprenorphine and Buprenorphine/naloxone in Detoxification of Opioid-dependent Men
por: Ziaaddini, Hassan, et al.
Publicado: (2018)

Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder
por: Laffont, Celine M., et al.
Publicado: (2022)

Buprenorphine as an adjuvant to local anesthetics in peripheral nerve blocks
por: Viswanath, Omar, et al.
Publicado: (2019)

The overshadowed opioid misuse pandemic
por: Cohen, Shaul, et al.
Publicado: (2022)

A review of the pharmacogenomics of buprenorphine for the treatment of opioid use disorder
por: Seguí, Hemanuel Arroyo, et al.
Publicado: (2020)

Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
por: Reed, Megan K, et al.
Publicado: (2022)

A need for consensus on mortality reporting related to the coronavirus disease-2019 pandemic in ongoing and future vascular registries and trials.
por: Valdivia, Andrés Reyes, et al.
Publicado: (2020)

The need for a disaster readiness mindset: A key lesson from the coronavirus disease 2019 (COVID-19) pandemic
por: Su, Zhaohui, et al.
Publicado: (2021)

Opioids during coronary interventions in cath lab – Need reconsideration?
por: Raut, Monish S, et al.
Publicado: (2020)

Coronavirus disease 2019 pandemic: Ethical concerns for the treatment of individuals with substance use disorders in India
por: Mahintamani, Tathagata, et al.
Publicado: (2020)

Advances in the delivery of buprenorphine for opioid dependence
por: Rosenthal, Richard N, et al.
Publicado: (2017)

Role of Buprenorphine in an Adolescent with Opioid Abuse
por: Weesner, Elizabeth, et al.
Publicado: (2022)

Comments on “a comparative study of sexual behavior, dysfunction, satisfaction, relationship, and sexual quality of life among treatment naïve and abstinent men (buprenorphine maintained) with opioid (heroin) dependence syndrome”
por: Singh, Gurvinder P., et al.
Publicado: (2023)

Hypogonadism and Low Testosterone Levels as a Side Effect of Methadone and Buprenorphine
por: Fareed, Ayman
Publicado: (2012)

Sublingual Buprenorphine: A Feasible Alternative for Treating Breakthrough Chronic Pain
por: Nair, Abhijit S, et al.
Publicado: (2019)

Buprenorphine for Medication-Assisted Treatment of Opioid Use Disorder in Pregnancy: Relationship to Neonatal Opioid Withdrawal Syndrome
por: Chavan, Niraj R., et al.
Publicado: (2017)

Mobile Telemedicine for Buprenorphine Treatment in Rural Populations With Opioid Use Disorder
por: Weintraub, Eric, et al.
Publicado: (2021)

Economic Evaluation of Extended-Release Buprenorphine for Persons With Opioid Use Disorder
por: Flam-Ross, Juliet M., et al.
Publicado: (2023)

Coronavirus disease 2019 (COVID-19): What we need to know
por: Javanian, Mostafa, et al.
Publicado: (2020)

The COVID-19 pandemic and opioid use disorder: Expanding treatment with buprenorphine, and combining safety precautions with telehealth
por: Cales, Richard H., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ej1i0c106v6545jhft5jbo851g